Actualités vTv Therapeutics Inc - VTVT | Actions NASDAQ | ADVFN

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
vTv Therapeutics Inc (VTVT)
vTv Therapeutics Inc (VTVT) Actualités

vTv Therapeutics Inc (VTVT)

14,85

0,29

(1,99%)

Fermé 15 Mars 9:00PM

Retardé de 15 minutes

14,85

0,00

(0,00%)

Après les heures de négociation: 9:06PM

Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Form 8-K - Current report

Form 8-K - Current report

CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER

CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN...

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING

CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

vTv Therapeutics

Kingdom of Spain

Yue Yuen Industrial (PK)

Themes US Infrastructure...

Vontobel Financial Produ...

BNP Paribas Issuance

Intesa Sanpaolo

Kairous Acquisition

BP Capital Markets

Intesa Sanpaolo

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales